Cargando…
Drug–drug interaction study of imatinib and voriconazole in vitro and in vivo
Background: In clinical practice, common problem polypharmacy could result in the increased risks of drug–drug interactions (DDIs). Co-administered imatinib (IMA) and voriconazole (VOR) as one treatment protocol in cancer patients with fungal infections are common.Purpose: The aim of the present stu...
Autores principales: | Lin, Qianmeng, Xie, Saili, Qiu, Xiangjun, Chen, Jingjing, Xu, Ren-Ai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502443/ https://www.ncbi.nlm.nih.gov/pubmed/31118708 http://dx.doi.org/10.2147/IDR.S199526 |
Ejemplares similares
-
Microdialysis of Drug and Drug Metabolite: a Comprehensive In Vitro Analysis for Voriconazole and Voriconazole N-oxide
por: Schulz, Josefine, et al.
Publicado: (2022) -
Drug–drug interactions with imatinib: An observational study
por: Récoché, Isabelle, et al.
Publicado: (2016) -
Pharmacokinetic Drug Interaction between Tofacitinib and Voriconazole in Rats
por: Lee, Ji-Sang, et al.
Publicado: (2021) -
Drug-drug interaction between voriconazole and oral hypoglycemic agents in diabetic rats
por: Kumar, Boyina Hemanth, et al.
Publicado: (2013) -
Voriconazole-induced Severe Hyperkalemia Precipitated by Multiple Drug Interactions
por: Choi, Jae Young, et al.
Publicado: (2020)